KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued (2016 - 2025)

Arbutus Biopharma's Shares Issued history spans 13 years, with the latest figure at $794000.0 for Q3 2025.

  • For Q3 2025, Shares Issued rose 329.19% year-over-year to $794000.0; the TTM value through Sep 2025 reached $3.9 million, up 882.37%, while the annual FY2024 figure was $396000.0, 52.31% up from the prior year.
  • Shares Issued for Q3 2025 was $794000.0 at Arbutus Biopharma, down from $3.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $3.0 million in Q2 2025 and bottomed at -$2.2 million in Q2 2024.
  • The 5-year median for Shares Issued is $199500.0 (2021), against an average of $367071.4.
  • The largest annual shift saw Shares Issued skyrocketed 729.05% in 2024 before it crashed 94.66% in 2025.
  • A 5-year view of Shares Issued shows it stood at $214000.0 in 2021, then plummeted by 99.53% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then skyrocketed by 18400.0% to $185000.0 in 2024, then surged by 329.19% to $794000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABUS's Shares Issued are $794000.0 (Q3 2025), $3.0 million (Q2 2025), and $131000.0 (Q1 2025).